Foghorn downgraded at TD Cowen on Lilly exit (FHTX:NASDAQ)
· seekingalpha.com
Foghorn Therapeutics (FHTX) stock slips after Eli Lilly (LLY) ends collaboration, prompting TD Cowen and others to downgrade the company. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...